40th week of 2011 patent applcation highlights part 62 |
Patent application number | Title | Published |
20110245455 | POLYIMIDE FILM - The present invention provides a polyimide film having a good transparency and also an excellent thermal resistance so that it is useful in a transparent conductive film, TFT substrate, a flexible printing circuit substrate, and the like. | 2011-10-06 |
20110245456 | BIODEGRADABLE POLYMER MICROPARTICLES AND PREPARATION METHOD THEREOF - The present invention relates to a preparation method for a biodegradable polymer microparticle and a microparticle prepared by the method. More particularly, the present invention relates to a method for preparing a polymer microparticle, wherein the method includes the steps of: dissolving a biodegradable polyester-based polymer in DMSO (Dimethyl Sulfoxide); spraying the solution in a low temperature hydrocarbon solution to provide a frozen DMSO microparticle; adding the microparticle in a low temperature salt aqueous solution to dissolve DMSO; and removing salt. The present invention provides a method for preparing a novel polymer microsphere which can be injected through a syringe due to excellent physical properties (such as biocompatibility, biodegradability, porosity, mechanical strength) and the microcarrier's size-adjustability, and can be easily mass-produced. The microparticle prepared by the method of the present invention may have variable sizes with biodegradability and biocompatibility, and thus can be used as a carrier for regeneration of a damaged cell or tissue by being injected into a body through a syringe. | 2011-10-06 |
20110245457 | SYSTEM AND METHOD FOR RECYCLING RESIN PARTICLES - A system and method for recycling resin particles. The system and method includes exposing resin particles to a solvent in a solvent wash tank. Within the tank, the solvent contacts the resin particles and substantially removes the contaminants. After the solvent wash, the resin particles are removed from the solvent and placed into a heated chamber of a dryer. The heated chamber facilitates the evaporation of residual solvent remaining on the resin particles, without the use of liquid or supercritical carbon dioxide, by facilitating the movement of the resin particles through the heated chamber while maintaining a heated environment within the heated chamber. In various embodiments, an alkyl lactate solvent is used in the wash tank and a vacuum may also be applied to the heated chamber, further facilitating the evaporation of the solvent off the resin particles. The system and method has been found to remove volatile polar, non-volatile polar, volatile non-polar, non-volatile non-polar substances, such as but not limited to: Benzophenone, 1-Phenyldecane, Toluene and Diethyl-Ketone, to levels that meet current FDA guidelines, including at or below 0.220 parts per million and 0.5 parts per billion after migration testing. | 2011-10-06 |
20110245458 | PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS - Disclosed is a peptide nucleic acid monomer as well as a corresponding peptide nucleic acid molecule. The monomer comprises a terminal amino group and a terminal group A. The terminal amino group and the terminal group A are connected by an aliphatic moiety. The main chain of this aliphatic moiety is free of groups that are charged under physiological conditions. The terminal group A is one of —COOH, —COOR | 2011-10-06 |
20110245459 | Processes for Intermediates for Macrocyclic Compounds - The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: | 2011-10-06 |
20110245460 | SOLVENT RESISTANT DIAFILTRATION OF PEPTIDES, PNA OR OLIGONUCLEOTIDES - According to the present invention, there is provided a process for the preparation of a first compound selected from peptides, oligonucleotides and peptide nucleic acids. The process comprises synthesising the first compound and then separating the first compound formed in step (i) from a second compound, which is a reaction by-product of the synthesis of the first compound and/or an excess of a reagent used for the synthesis of a first compound by a process of diafiltration. The membrane used for the diafiltration process is stable in organic solvents and provides a rejection for the first compound which is greater than the rejection for the second compound. | 2011-10-06 |
20110245461 | METHODS FOR DETERMINING THE RETENTION OF PEPTIDES IN REVERSE PHASE CHROMATOGRAPHY USING LINEAR SOLVENT STRENGTH THEORY - The present disclosure relates to methods for separating or isolating a peptide using reverse phase chromatography. The disclosure also relates to methods for calculating or determining the slope S of a peptide, wherein S is defined according to the Linear-Solvent-Strength equation log k=log k | 2011-10-06 |
20110245462 | Non-Fluorescent Quencher Compounds and Biomolecular Assays - Bis-diazo, triaryl and aryldiazo-N-arylphenazonium quencher moieties, substituted with electron-withdrawing and electron-donating substituents which induce polarity in the delocalized aryl/diazo ring systems, are useful as labels when attached to biomolecules such as polynucleotides, nucleosides, nucleotides and polypeptides. The quencher moieties are non-fluorescent and accept energy transfer from fluorescent reporter labels by any energy-transfer mechanism, such as FRET. | 2011-10-06 |
20110245463 | APPARATUS AND METHOD FOR STRUCTURE-BASED PREDICTION OF AMINO ACID SEQUENCES - The present invention provides methods and apparatus for analyzing a protein structure. | 2011-10-06 |
20110245464 | HIGHLY THERMOSTABLE FLUORESCENT PROTEINS - Thermostable fluorescent proteins (TSFPs), methods for generating these and other stability-enhanced proteins, polynucleotides encoding such proteins, and assays and method for using the TSFPs and TSFP-encoding nucleic acid molecules are provided. The TSFPs of the invention show extremely enhanced levels of stability and thermotolerance. In one case, for example, a TSFP of the invention is so stable it can be heated to 99° C. for short periods of time without denaturing, and retains 85% of its fluorescence when heated to 80° C. for several minutes. The invention also provides a method for generating stability-enhanced variants of a protein, including but not limited to fluorescent proteins. | 2011-10-06 |
20110245465 | Methods for Detection of Methyl-CpG Dinucleotides - The invention provides methods for enriching methyl-CpG sequences from a DNA sample. The method makes use of conversion of cytosine residues to uracil under conditions in which methyl-cytosine residues are preserved. Additional methods of the invention enable to preservation of the context of me-CpG dinucleotides. The invention also provides a recombinant, full length and substantially pure McrA protein (rMcrA) for binding and isolation of DNA fragments containing the sequence 5′-C | 2011-10-06 |
20110245466 | METHOD OF PRODUCTION OF POLYANIONIC DRUG-CARRIER CONJUGATES - The invention concerns the method of production of a polyanionic macromolecule which is a protein built, among others, form polar amino acids (such as lysine, arginine, aspartic acid, glutamic acid), characteristic in that, that as a result of the reaction between amine groups and the cyclic anhydride of dicarboxylic acid, the charge changes towards more negatively charged carrier. This reaction gives rise to better therapeutic properties of macromolecules modified in this way. | 2011-10-06 |
20110245467 | Rapid, Sensitive and Quantitative Methods for Tissue and Cell-Based Proteomics Via Consecutive Addition of Quantifiable Extenders - Methods, systems and kits are provided for detecting and quantifying multiple immunogens in a sample via consecutive addition of quantifiable extenders to immunogen bound complexes of immunogen binding agent attached to a DNA containing an RNA polymerase promoter. | 2011-10-06 |
20110245468 | B7-H5, A COSTIMULATORY POLYPEPTIDE - B7-HS costimulatory polypeptides, nucleic acids encoding such polypeptides, and methods for using the polypeptides and nucleic acids to enhance a T cell response are provided herein. | 2011-10-06 |
20110245469 | INTERMEDIATES FORMED IN BIOSYNTHESIS OF RELAXIN-FUSION PROTEINS WITH EXTENDED IN VIVO HALF-LIVES - Disclosed are human relaxin-Fc fusion proteins having an increased serum half-life, polynucleotides encoding the same, and intermediates formed during the fusion protein biosynthesis. The fusion proteins may include a linker portion or other sections as well. Suitable fusion proteins are also those predicted to have the same effect as human relaxin in vivo, based, for example, on structural modeling. The fusion protein is useful in the treatment of a number of diseases and conditions, including heart disease, vascular disease, wound healing, fibrosis, fibromyalgia, and promoting angiogenesis. | 2011-10-06 |
20110245470 | IMMUNOGLOBULINS - The present invention concerns immunoglobulins, such as antibodies, which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and modulate the interaction between OSM and gp130. In typical embodiments, OSM is glycosylated. The invention also concerns antibodies that modulate the interaction between both Site II and Site III of OSM and their respective interacting partners. Further disclosed are pharmaceutical compositions, screening and medical treatment methods. | 2011-10-06 |
20110245471 | NUCLEAR FACTOR kappaB INDUCING FACTOR - The present invention is directed to nuclear factor κB (NFκB)-inducing factor polypeptides (NFIF polypeptides) which are capable of inducing NFκB. The present invention includes within its scope NFIF polypeptides, including NFIF-14b and NFIF-7a, DNA, including cDNA, encoding these polypeptides, and expression vectors capable of expressing NFIF polypeptides. Also included are methods and compositions for increasing NFκB induction in a patient, methods and compositions for lowering NFκB induction in a patient, methods for inhibiting inflammation, and methods for manufacutre of a medicament intended for the treatment and/or prevention of an NFκB-regulated inflammatory response. In addition, methods for determining whether a test compound inhibits or enhances the activity of NFIF polypeptides are provided. | 2011-10-06 |
20110245472 | METHOD FOR THE MASS PRODUCTION OF IMMUNOGLOBULIN CONSTANT REGION - Disclosed are a recombinant expression vector comprising a nucleotide sequence encoding an | 2011-10-06 |
20110245473 | Anti-IL-6 Receptor Antibody - The present inventors succeeded in discovering specific amino acid mutations in the variable region, framework region, and constant region of TOCILIZUMAB, and this enables to reduce immunogenicity risk and the heterogeneity originated from disulfide bonds in the hinge region, as well as to improve antigen binding activity, pharmacokinetics, stability under acidic conditions, and stability in high concentration preparations. | 2011-10-06 |
20110245474 | METHODS FOR G-CSF PRODUCTION IN A PSEUDOMONAS HOST CELL - The present invention relates to the field of recombinant protein production in bacterial hosts. It further relates to expression of soluble, active recombinant protein by using secretion signals to direct the protein to the periplasmic space of a bacterial cell. In particular, the present invention relates to a production process for obtaining soluble hG-CSF protein from a bacterial host. | 2011-10-06 |
20110245475 | AZO PIGMENT, PROCESS FOR PRODUCING AZO PIGMENT, DISPERSION CONTAINING AZO PIGMENT, AND COLORING COMPOSITION - There is provided an azo pigment having excellently good color reproducibility, dispersibility, and storage stability of pigment dispersions and having excellent hue and tinctorial strength. | 2011-10-06 |
20110245476 | ANTIBACTERIAL 4,6-SUBSTITUTED 6', 6" AND 1 MODIFIED AMINOGLYCOSIDE ANALOGS - The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection. | 2011-10-06 |
20110245477 | EFFICIENT METHODS FOR Z- OR CIS-SELECTIVE CROSS-METATHESIS - The present invention generally relates to methods for performing metathesis reactions, including cross-metathesis reactions. Methods described herein exhibit enhanced activity and stereoselectivity, relative to known methods, and are useful in the synthesis of a large assortment of biologically and therapeutically significant agents. | 2011-10-06 |
20110245478 | Method for the Synthesis of Oligonucleotide Derivatives - Method for the synthesis of nucleotide derivatives wherein molecules of interest are grafted on the oligonucleotide with the help of a “click chemistry” reaction between an azide function on the molecule of interest and an alkyne function on the oligonucleotide, or between an alkyne function on the molecule of interest and an azide function on the oligonucleotide. | 2011-10-06 |
20110245479 | Method for Generating Aptamers with Improved Off-Rates - The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element. | 2011-10-06 |
20110245480 | ENGINEERED LISTERIA AND METHODS OF USE THEREOF - The invention provides a bacterium containing a polynucleotide comprising a nucleic acid encoding a heterologous antigen, as well as fusion protein partners. Also provided are vectors for mediating site-specific recombination and vectors comprising removable antibiotic resistance genes. | 2011-10-06 |
20110245481 | METHOD FOR INHIBITING FUNCTION OF micro-RNA - A miRNA-inhibiting RNA complex has a double-stranded structure, in which at least one RNA strand that includes a miRNA-binding sequence is linked to the two strands at at least one end of the double-stranded structure. The complex can efficiently inhibit miRNAs. In particular, RNAs in which two RNAs containing a miRNA binding sequence are positioned between two double-stranded structures were able to strongly inhibit miRNA. These RNAs can be expressed from, for example, a PolIII promoter, and by integration into a vector, miRNAs can be stably inhibited for a long period of time. | 2011-10-06 |
20110245482 | NON-INVASIVE DETECTION OF FETAL GENETIC TRAITS - Blood plasma of pregnant women contains fetal and (generally>90%) maternal circulatory extracellular DNA. Most of said fetal DNA contains ≦500 base pairs, said maternal DNA having a greater size. Separation of circulatory extracellular DNA of <500 base pairs results in separation of fetal from maternal DNA. A fraction of a blood plasma or serum sample of a pregnant woman containing, due to size separation (e.g. by chromatography, density gradient centrifugation or nanotechnological methods), extracellular DNA substantially comprising ≦500 base pairs is useful for non-invasive detection of fetal genetic traits (including the fetal RhD gene in pregnancies at risk for HDN; fetal Y chromosome-specific sequences in pregnancies at risk for X chromosome-linked disorders; chromosomal aberrations; hereditary Mendelian genetic disorders and corresponding genetic markers; and traits decisive for paternity determination) by e.g. PCR, ligand chain reaction or probe hybridization techniques, or nucleic acid arrays. | 2011-10-06 |
20110245483 | Method For Purification Of Nucleic Acids, Particularly From Fixed Tissue - The invention relates to a method for purification of nucleic acids, to a kit for performing the method according to the invention and to a new application of magnetic particles for purification of a biological sample. The method according to the invention comprises the following steps: a) accommodating of the sample in a first sample vessel in an aqueous solution and lysing of the sample under non-chaotropic conditions; suspending of first magnetic particles in the solution and inserting of the first sample vessel in a sample vessel holder, wherein the sample vessel is inserted in the annular interior space of a ring magnet associated with the sample vessel holder; separating of the solution from the magnetic particles; and isolating of the nucleic acids from the solution. | 2011-10-06 |
20110245484 | STEREOSELECTIVE SYNTHESIS OF PHOSPHORUS CONTAINING ACTIVES - Disclosed herein are phosphorus-containing actives, their use as actives for treating diseases, and a stereoselective process for preparing the same. Also disclosed herein are useful synthetic intermediates and processes for preparing the same. | 2011-10-06 |
20110245485 | PROCESS FOR THE SYNTHESIS OF AZACITIDINE AND DECITABINE - Described herein is a process for the synthesis of azacitidine or decitabine, comprising the silylation of azacytosine in the presence of N,O-bis-trimethylsilyl-trifluoroacetamide. Such reaction is performed in an organic solvent, preferably aprotic, even more preferably selected from among dichloromethane, dichloroethane and/or acetonitrile. According to a further aspect of the process, 2 to 3 moles of N,O-bis-trimethylsilyl-trifluoroacetamide are used per mole of azacytosine, preferably from 2.2 to 2.5. | 2011-10-06 |
20110245486 | METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES - The invention relates to a method for producing 1,4-benzothiepin-1,1-dioxide derivatives substituted with benzyl groups. | 2011-10-06 |
20110245487 | SEPARATION PROCESS - The invention relates to a multiprofile chromatographic sequential SMB process of separating and recovering betaine and sucrose from concentrated raw juice or thick juice. In the process of the invention, the betaine subprofile and the residual subprofile of successive separation profiles are overlapping. A sucrose fraction and a betaine fraction containing also residual components are recovered. Betaine is further separated from the betaine fraction for example by chromatographic processes. | 2011-10-06 |
20110245488 | PROCESS FOR THE SYNTHESIS OF L-FUCOSYL DI- OR OLIGO-SACCHARIDES AND NOVEL 2,3,4 TRIBENZYL-FUCOSYL DERIVATIVES INTERMEDIATES THEREOF - The present invention relates to a process for the synthesis of L-fucosyl di- or oligosaccharides and their novel 2,3,4-tri-O-benzyl-fucosyl synthetic intermediates derivatives of easy crystallization. In particular the present invention relates to a process applicable to industrial scale for the synthesis of 2′O-fucosyl lactose. | 2011-10-06 |
20110245489 | METHOD OF INCREASING ANHYDROSUGARS, PYROLIGNEOUS FRACTIONS AND ESTERIFIED BIO-OIL - The device and method of this invention provides a means to increase anhydrosugars yield during pyrolysis of biomass. This increase is achieved by injection of a liquid or gas into the vapor stream of any pyrolysis reactor prior to the reactor condensers. A second novel feature of our technology is the utilization of sonication, microwave excitation or shear mixing of the biomass to increase the acid catalyst rate for demineralization or removal of hemicellulose prior to pyrolysis. The increased reactivity of these treatments reduces reaction time as well as the required amount of catalyst to less than half of that otherwise required. A fractional condensation system employed by our pyrolysis reactor is also a novel element of our technology. This system condenses bio-oil pyrolysis vapors to various desired fractions by differential temperature manipulation of individual condensers comprising a condenser chain. | 2011-10-06 |
20110245490 | C-GLYCOSIDE COMPOUNDS, AND METHOD FOR PREPARING C-GLYCOSIDE COMPOUNDS - The invention relates to C-glycose compounds of formula (I) where: S′ is a monosaccharide radical or a polysaccharide radical derived from a monosaccharide or polysaccharide S; R is a linear or branched alkyl radical; and Z is an ethylenyl CH═CR1(R2) or an acetylenyl C≡CR3 radical. The invention also relates to a method for preparing C-glycoside compounds of formula (III), characterised in that the method consists of a step of reacting a sugar (S), in an aqueous solvent or in the absence of a solvent and in the presence of an organic or mineral base (B), with a phosphonate of formula (II) according to the following reaction pattern: Formulas (II), (III). | 2011-10-06 |
20110245491 | SEPARATION PROCESS - The invention relates to a three-profile chromatographic sequential SMB process of separating and recovering products such as sugars and betaine from multicomponent feed solutions. In the process of the invention, product fractions and optionally recycle fractions are collected from several positions of the chromatographic separation system. The process of the invention may be applied to the separation of sucrose and betaine from sugar beet based solutions and to the separation of sugars, e.g. xylose, from plant-based hydrolysates, for example. | 2011-10-06 |
20110245492 | NOVEL ALLELIC VARIANT OF CYP2C19 ASSOCIATED WITH DRUG METABOLISM - The invention provides methods, PCR primers and sequence determination oligonucleotides for determining a human's capacity to metabolise a substrate of the CYP2C19 enzyme using genetic analysis. | 2011-10-06 |
20110245493 | DELIVERY OF DRUG AMINES THROUGH AN INHALATION ROUTE - The present invention relates to the delivery of drug amines through an inhalation route. Specifically, it relates to aerosols containing drug amines that are used in inhalation therapy. In one aspect of the present invention, a method of delivering an amine drug in an aerosol form is provided. The method comprises: a) heating a coating, which includes an amine drug salt on a substrate contained in a device to a temperature sufficient to volatilize the amine drug from the coating, h) by said heating, forming an amine drug vapor, and c) during said heating, drawing air through said device, condensing said vapor to form aerosol particles containing less than 10% degradation products of the compound. | 2011-10-06 |
20110245494 | PROCESSES AND INTERMEDIATES FOR MAKING SWEET TASTE ENHANCERS - The present invention includes methods/processes and intermediates for preparing compounds having structural Formula (I): | 2011-10-06 |
20110245495 | Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device - An object is to provide a novel organometallic complex capable of emitting phosphorescence by using, as a ligand, an organic compound with which a variety of derivatives can be easily synthesized. Another object is to provide an organometallic complex having high heat resistance. Other objects are to provide a light-emitting element having high emission efficiency and to provide a light-emitting device, an electronic device, and a lighting device having reduced power consumption. Provided are an organometallic complex including a structure represented by the following General Formula (G1), and a light-emitting element, a light-emitting device, an electronic device, and a lighting device formed using the organometallic complex including the structure represented by the following General Formula (G1). | 2011-10-06 |
20110245496 | Quinazoline Salt Compounds - Salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity. | 2011-10-06 |
20110245497 | OPTICAL RESOLUTION OF SUBSTITUTED 1, 3-OXATHIOLANE NUCLEOSIDES - Cis(±)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone is reacted with S(+)-1,1′-binaphthyl-2,2′-diyl hydrogen phosphate in methanol to obtain diastereomeric compounds. The diastereomeric compounds are subjected to selective crystallization to obtain (2R-Cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone 1,1′-binaphthyl-2,2′-diyl hydrogen phosphate. (2R-Cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone 1,1′-binaphthyl-2,2′-diyl hydrogen phosphate is treated with hydrochloric acid in water to obtain (2R-cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone. | 2011-10-06 |
20110245498 | SOLID STATE FORMS OF SITAGLIPTIN SALTS - Crystalline forms of Sitagliptin salts, processes for preparing crystalline forms of Sitagliptin salts, and pharmaceutical compositions of Sitagliptin salts are provided. | 2011-10-06 |
20110245499 | Process for Resolving Zopiclone - The present invention provides a process for the preparation of the dextrorotatory isomer of zopiclone (eszopiclone). The present invention also provides eszopiclone di-p-anisolyl-L-tartrate and eszopiclone diacetyl-L-tartrate, which are useful as intermediates in a process for preparing eszopiclone. | 2011-10-06 |
20110245500 | MELANOCORTIN RECEPTOR AGONISTS - The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient. | 2011-10-06 |
20110245501 | Substituted Tetracycline Compounds as Synergistic Antifungal Agents - The present invention relates to substituted tetracycline compounds and related methods for increasing the antifungal activity of an antifungal agent. The methods include administering to a subject an effective amount of a substituted tetracycline compound in combination with an antifungal agent such that the subject is treated for the fungal associated disorder. | 2011-10-06 |
20110245502 | LIGHT-EMITTING ELEMENT AND IRIDIUM COMPLEX - A light-emitting element having excellent light-emitting properties and with which it is possible to emit blue light at a high luminance for a long period of time, and an iridium complex for realizing the same. The light-emitting element has an external quantum efficiency of at least 5% and a light emission maximum wavelength λ max of no more than 500 nm. Further, there is provided a light-emitting element including a light-emitting layer or a plurality of organic compound layers having the light-emitting layer, with at least one of the compound layers including at least one kind of a compound having a partial structure represented by the general formula K-0. In the general formula K-0, R | 2011-10-06 |
20110245503 | ENANTIOSELECTIVE SYNTHESIS OF ASYMMETRIC BETA-CARBOLINE INTERMEDIATES - Described herein is a new asymmetric synthesis of imines to obtain β-carboline derivatives useful as key intermediate compounds for the synthesis of phosphodiesterase inhibitors using a new process with palladium or ruthenium hydride and/or nickel boride to reduce chiral intermediates. The use of chloroformate chiral auxiliaries is further described for the reduction and asymmetric hydrogenation of imines to obtain β-carboline derivatives and intermediate compounds used in the preparation thereof. | 2011-10-06 |
20110245504 | SYNTHESIS OF 9-(ARYLALKYL)-1,2,3,4-TETRAHYDRO-y-CARBOLINE AND ANALOGUES AND INTERMEDIATES - The present invention pertains generally to methods of preparing certain 9-(arylalkyl)-1,2,3,4-tetrahydro-γ-carboline compounds and their analogues, and especially to methods of preparing dimebon. The present invention also pertains to methods of preparing certain intermediate compounds which find use in the synthesis of the 9-(arylalkyl)-1,2,3,4-tetrahydro-γ-carboline compounds. | 2011-10-06 |
20110245505 | Process for Manufacturing 5-Formyl-Pyridine-2,3-Dicarboxylic Acid Esters - A process for manufacturing a 5-formyl-pyridine-2,3-dicarboxylic acid ester (I) wherein Z is hydrogen or halogen; Z | 2011-10-06 |
20110245506 | Process for Manufacturing Substituted 5-Methoxymethylpyridine-2,3-Dicarboxylic Acid Derivatives - A process for manufacturing a 2,3-disubstituted-5-methoxymethylpyridine of formula (I), where Z is H or halogen; Z | 2011-10-06 |
20110245507 | 1,2,3-TRIAZOLE BOUND BORANE COMPOUNDS, SYNTHESIS OF, AND USE IN REDUCTION REACTIONS - A 1,2,3-triazole coordinated borane such as | 2011-10-06 |
20110245508 | Processes For Making Pregabalin And Intermediates Therefor - Processes for making a diester compound of formula (B) and for converting it to pregabalin, especially via a compound of formula (2), can provide several advantages. | 2011-10-06 |
20110245509 | POLYFUNCTIONAL POLYOXYALKYLENE COMPOUND, AND PRODUCING METHOD AND INTERMEDIATE THEREOF - A polyfunctional polyoxyalkylene compound represented by the following formula (1): | 2011-10-06 |
20110245510 | PROCESS FOR REMOVING BY-PRODUCTS FROM N-VINYLAMIDES - A process for removing by-products from N-vinylamide-rich product mixtures (crude N-vinylamide), which comprises performing an extraction of the crude N-vinylamide with an organic solvent as the extractant. | 2011-10-06 |
20110245511 | Intermediates for Hydroxylated Contrast Enhancement Agents - In one aspect, the present invention provides a protected ligand precursor having structure XX | 2011-10-06 |
20110245512 | HYDROXYLATED CONTRAST ENHANCEMENT AGENTS - In one aspect, the present invention provides a contrast enhancement agent comprising an iron chelate having structure I and salts thereof | 2011-10-06 |
20110245513 | SYNTHESIS PROCESS OF POLYOL CARBONATE FROM POLYOLS, CONDUCTED IN USING A SOLVENT SELECTIVE FOR POLYOLS CARBONATES - The present invention relates to a synthesis process of polyol carbonate, such as glycerol carbonate, from polyols such as glycerol, propylene glycol or ethylene glycol and urea conducted in using a solvent selective for polyols (glycerol) carbonates. Said process comprises reacting polyol with urea in the presence of a catalyst, extracting produced NH | 2011-10-06 |
20110245514 | PROCESSES FOR THE PRODUCTION OF HYDROGENATED PRODUCTS - A process for making a hydrogenated product includes providing a clarified DAS-containing fermentation broth; distilling the broth under super atmospheric pressure at a temperature of >100° C. to about 300° C. to form an overhead that includes water and ammonia, and a liquid bottoms that includes SA, and at least about 20 wt % water; cooling the bottoms to a temperature sufficient to cause the bottoms to separate into a liquid portion in contact with a solid portion that is substantially pure SA; separating the solid portion from the liquid portion; recovering the solid portion; hydrogenating the solid portion in the presence of at least one hydrogenation catalyst to produce the hydrogenated product including at least one of THF, GBL or BDO; and recovering the hydrogenated product. | 2011-10-06 |
20110245515 | PROCESSES FOR THE PRODUCTION OF HYDROGENATED PRODUCTS - A process for making a hydrogenated product includes providing a clarified DAS-containing fermentation broth, distilling the broth to form an overhead that includes water and ammonia, and a liquid bottoms that includes MAS, at least some DAS, and at least about 20 wt % water, cooling and/or evaporating the bottoms, and optionally adding an antisolvent to the bottoms, to attain a temperature and composition sufficient to cause the bottoms to separate into a DAS-containing liquid portion and a MAS-containing solid portion that is substantially free of DAS, separating the solid portion from the liquid portion, recovering the solid portion, hydrogenating the second solid portion in the presence of at least one hydrogenation catalyst to produce the hydrogenated product comprising at least one of THF, GBL or BDO, and recovering the hydrogenated product. | 2011-10-06 |
20110245516 | MALTOL ETHER PROCESSES AND INTERMEDIATES - Novel processes and intermediates are provided according to the general reaction scheme: Formula I, II, III, IV (I), (II), (III), (IV) utilizing a ruthenium catalyst in an oxidative cleavage of the triene 4 whereby an aldehyde may be produced and optionally taken on to a carboxylic acid 5: Formula V (V) | 2011-10-06 |
20110245517 | PROCESS FOR PREPARING TETRAHYDROFURAN - The present invention relates to a process for preparing tetrahydrofuran by absorption of C | 2011-10-06 |
20110245518 | CATALYST FOR PRODUCTION OF ETHYLENE OXIDE AND METHOD FOR PRODUCTION OF ETHYLENE OXIDE - A catalyst for the production of ethylene oxide in high efficiency and high selectivity, as well as stably for a long period of time is provided. | 2011-10-06 |
20110245519 | Purification of propylene oxide - The invention is a method of purifying propylene oxide containing 25-100 ppm aldehyde impurities. The method comprises contacting the propylene oxide in the liquid phase with an amine-functionalized ion exchange resin, and recovering a purified propylene oxide product containing 10 ppm, or less, aldehydes. | 2011-10-06 |
20110245520 | METHOD OF MAKING FLUORINATED ALKOXY CARBOXYLIC ACIDS AND PRECURSORS THEREOF - A method for preparing saturated partially fluorinated alkoxy carboxylic acids or salts thereof by treating a compound: (II), where R | 2011-10-06 |
20110245521 | USE OF METHANESULFONIC ACID FOR PREPARING FATTY ACID ESTERS - The present invention relates to a process for preparing fatty acid esters and/or fatty acid ester mixtures of monohydric alcohols having 1 to 5 carbon atoms by transesterifying fatty acid glycerides with monohydric alcohols in the presence of a basic catalyst, in the course of which methanesulfonic acid is used. The invention further relates to the use of methanesulfonic acid for preparing these fatty acid esters. | 2011-10-06 |
20110245522 | Method of Fabricating Fatty Acid Methyl Ester by Using Bronsted Acid Ionic Liquid - A new method for fabricating fatty acid methyl ester (FAME) is provided. A Bronsted acid ionic liquid is used. After some reactions, two layers of materials are formed. A product of FAME is obtained at the upper layer of material. The lower layer of material is the ionic liquid. Thus, the ionic liquid is reusable for re-fabricating the FAME product. And, furthermore, waste acid is thus reduced. | 2011-10-06 |
20110245523 | SINGLE STEP TRANSESTERIFICATION OF BIODIESEL FEEDSTOCK USING A GASEOUS CATALYST - Embodiments of the present application provide methods for processing biodiesel from feedstock using a single-step process. The methods can include, for example, use of a gaseous catalyst as part of the esterification/transesterification process. Embodiments of the present application also provide systems for the methods thereof. | 2011-10-06 |
20110245524 | PROCESS FOR THE ENRICHMENT OF METHYL RICINOLEATE FROM CASTOR OIL METHYL ESTERS BY LIQUID-LIQUID EXTRACTION - The present invention provides a process for the enrichment of methyl ricinoleate from castor oil methyl esters by liquid-liquid extraction (LLE) in presence of refined vegetable oils using an aqueous polar solvent. The invention provides an extraction of methyl ricinoleate by a non-destructive extraction method with good yields (75 to 90%) and purity (95 to 99%). The method consists of mixing castor oil methyl esters in a refined normal vegetable oil (feed) in a suitable proportion and selective extraction of methyl ricinoleate in a non-destructive manner by liquid-liquid extraction using a polar aqueous solvent, followed by de-solventization and drying of the solute to get enriched methyl ricinoleate fraction with good yields. The non-hydroxy fatty acid methyl esters of castor oil methyl esters are retained in the vegetable oil and can be used for the preparation of biodiesel or oelochemicals or reused in the process for the enrichment of methyl ricinoleate after removal of non-hydroxy fatty acid either by distillation under reduced pressure or further by liquid-liquid extraction using pure solvent. | 2011-10-06 |
20110245525 | NORBORNANE SKELETON STRUCTURE-CONTAINING ORGANOSILICON COMPOUND AND METHOD OF PRODUCING SAME - Disclosed are a radiation-polymerizable functional group-containing organosilicon compound, including (A) a norbornane skeleton structure, (B) a hydrolyzable silyl group bonded directly to the norbornane skeleton structure, and (C) a radiation-polymerizable functional group bonded to the norbornane skeleton structure, either directly or via a carbon atom, a hetero atom, or a combination thereof, and a method of producing the radiation-polymerizable functional group-containing organosilicon compound. Also disclosed are a haloalkyl group-containing organosilicon compound, including (D) a norbornane skeleton structure, (E) a hydrolyzable silyl group bonded directly to the norbornane skeleton structure, and (F) a haloalkyl group, which is bonded directly to the norbornane skeleton structure and either contains or does not contain a hetero atom, and a method of producing the haloalkyl group-containing organosilicon compound. These organosilicon compounds are useful as silane coupling agents having superior heat resistance stability. | 2011-10-06 |
20110245526 | Process of Extracting Isothiocyanates - A process for producing an essential oil. The essential oil can be white mustard essential oil. The white mustard essential oil can include a moisture sensitive isothiocyanate compound. The moisture sensitive isothiocyanate compound can be 4-HBITC. The essential oil can be produced from mustard seed, which can comprise a precursor sinalbin and myrosinase enzyme. The mustard seed can be reduced into a powder. Activation of the myrosinase enzyme by using a water solvent and a promoter to form a slurry can be performed, wherein the myrosinase enzyme catalyzes the production of an essential oil comprising an isothiocyanate from the sinalbin precursor. | 2011-10-06 |
20110245527 | PROCESS FOR PREPARING DIARYL CARBONATES AND POLYCARBONATES - The present invention relates to a process for the continuous preparation of diaryl carbonates from phosgene and at least one monohydroxy compound (monophenol) in the presence of catalysts, and also the use thereof for preparing polycarbonates. The hydrogen chloride formed in the reaction is converted by thermal oxidation into chlorine, with the chlorine being recirculated to the preparation of phosgene. In particular, the process comprises utilization of the hydrogen chloride formed for the process for preparing diphenyl carbonate (DPC process). | 2011-10-06 |
20110245528 | THERAPEUTIC COMPOUNDS - The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention. | 2011-10-06 |
20110245529 | METHOD FOR PRODUCING OPTICALLY ACTIVE VINYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVE AND OPTICALLY ACTIVE VINYLCYCLOPROPANEAMINO ACID DERIVATIVE - The objective of the present invention is to provide a method for obtaining an optically active vinylcyclopropanecarboxylic acid derivative with high yield and high optical purity using a safe material available at low cost. In addition, the objective of the present invention is to provide a method for safely-obtaining an optically active vinylcyclopropaneamino acid with high optical purity at low cost. The problems can be solved by a method for obtaining an optically active vinylcyclopropanecarboxylic acid derivative, which method contains the step of reacting a racemic vinylcyclopropanecarboxylic acid derivative with an optically active amine compound, to obtain a diastereomer salt of optically active vinylcyclopropanecarboxylic acid derivative-amine compound. In addition, it is possible to obtain a vinylcyclopropaneamino acid by deriving the vinylcyclopropaneamino acid from thus obtained diastereomer salt of optically active vinylcyclopropanecarboxylic acid derivative-amine compound. | 2011-10-06 |
20110245530 | PROCESS FOR PRODUCING PENTAERYTHRITOL MERCAPTOCARBOXYLIC ESTERS AND POLYMERIZABLE COMPOSITIONS CONTAINING THE ESTERS - A process for producing pentaerythritol mercaptocarboxylic ester by reacting pentaerythritol with a mercaptocarboxylic acid having a content of thioester formed by condensation of two molecules of the acid of 5% or below (in terms of area percentage) as determined by the high-performance liquid chromatography in the case of the total area of the mercaptocarboxylic acid and thioester formed by intermolecular condensation of the acid is taken as 100%. | 2011-10-06 |
20110245531 | PROCESS FOR PRODUCING PENTAERYTHRITOL MERCAPTOCARBOXYLIC ACID ESTER, PENTAERYTHRITOL MERCAPTOCARBOXYLIC ACID ESTER OBTAINED BY THE SAME, AND USE THEREOF - Pentaerythritol which contains none of the alkali metals and the alkaline earth metals or which contains at least one of these in a total amount of 1.0 weight % or smaller is reacted with a mercaptocarboxylic acid to produce a pentaerythritol mercaptocarboxylic acid ester. | 2011-10-06 |
20110245532 | METHANOL DEHYDROGENATION CATALYST FOR PRODUCING OF METHYL FORMATE AND METHOD FOR PRODUCING METHYL FORMATE - A methanol dehydrogenating catalyst used for production of methyl formate, which contains a copper-zinc-aluminum oxide, a phosphoric acid compound, and an alkali metal bromide, wherein the catalyst has high methyl formate selectivity and excellent durability and heat resistance; and a method of producing methyl formate by using the catalyst. | 2011-10-06 |
20110245533 | NANOPARTICLE INCLUDING MULTI-FUNCTIONAL LIGAND AND METHOD - A nanoparticle including an inorganic core comprising at least one metal and/or at least one semi-conductor compound comprising at least one metal includes a coating or shell disposed over at least a portion of a surface of the core. The coating can include one or more layers. Each layer of the coating can comprise a metal and/or at least one semiconductor compound. The nanoparticle further includes a ligand attached to a surface of the coating. The ligand is represented by the formula: X-Sp-Z, wherein: X represents: a primary amine group, a secondary amine group, a urea, a thiourea, an imidizole group, an amide group, a carboxylic acid or carboxylate group; a phosphoric acid group, a phosphate group, a phosphite group, a phosphinic acid group, a phosphinate group, a phosphine oxide group, a phosphinite group, a phosphine group, an arsenic acid group, an arsenate group, an arsenous acid group, an arsenite group, an arsinic acid group, an arsine oxide group, or an arsine group; Sp represents a group capable of allowing a transfer of charge or an insulating group; and Z represents a multifunctional group including three or more functional groups capable of communicating a specific property or chemical reactivity to the nanoparticle, wherein at least three of the functional groups are chemically distinct, and wherein Z is not reactive upon exposure to light. Compositions including a nanoparticle in accordance with the invention are also disclosed. Devices including nanoparticle and/or composition in accordance with the invention are disclosed. Methods for preparing nanoparticles in accordance with the invention are disclosed. Other products including a nanoparticle in accordance with the invention are also disclosed. | 2011-10-06 |
20110245534 | NOVEL POLYMORPHIC FORM OF CHDMAPP, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME - The present invention relates to novel polymorphs of (2E)-1-hydroxy-2-methylpent-2-enyl-pyrophosphonate disodium (CHDMAPP-Na | 2011-10-06 |
20110245535 | MULTI-METAL OXIDE CATALYST AND METHOD FOR PRODUCING (METH)ACRYLIC ACID BY USING THE SAME - The present invention provides a Mo—Bi—Nb based composite metal oxide (with the proviso that Te is not included); a method for producing (meth)acrylic acid from at least one reactant selected from the group consisting of propylene, propane, isobutylene, t-butyl alcohol and methyl-t-butyl ether, in which a Mo—Bi—Nb based composite metal oxide (with the proviso that Te is not included) is used as a catalyst; and a reactor used for producing (meth)acrylic acid from at least one reactant selected from the group consisting of propylene, propane, isobutylene, t-butyl alcohol and methyl-t-butyl ether, in which a Mo—Bi—Nb based composite metal oxide (with the proviso that Te is not included) is used as a catalyst. Further, the present invention provides a method for producing the (meth)acrylic acid without any additional process of converting (meth)acrolein into (meth)acrylic acid. | 2011-10-06 |
20110245536 | PROCESS FOR PREPARING PREGABALIN - Disclosed herein is an improved, commercially viable and industrially advantageous process for the preparation of pregabalin in high yield and purity. The present invention also provides a process for the purification of (S)-pregabalin. | 2011-10-06 |
20110245537 | L-carnitine calcium fumarate, preparation method and application for the same - L-carnitine calcium fumarate and its preparation and applications are disclosed in the present invention. Having good water solubility as well as better and stronger nutritious and treating functions than the corresponding inner salts, the L-carnitine calcium fumarate as proposed having the advantages of being non-hygroscopic, stable in chemical property, and suitable for oral administration. A preparing method is as follow: fumaric acid is suspended in water and calcium base is added. The resulting mixture is heated up to 70˜90° C. and kept under stirring for 2˜8 hours, and then concentrated under reduced pressure. The resulting dried substance is added into ethanol, and the mixture is vigorously stirred. The inner salt of L-carnitine is added, and the mixture is reacted for 1˜6 hours at 60˜70° C. and then cooled for 2˜8 hours. L-carnitine calcium fumarate is obtained by filtration. | 2011-10-06 |
20110245538 | SQUARYLIUM COMPOUND, METHOD FOR PRODUCING THE SAME AND INFRARED ABSORBENT - Provide is a compound having absorbability in an infrared region, excellent invisibility and robustness. The compound is a squarylium compound represented Formula (1): | 2011-10-06 |
20110245539 | PROCESS FOR THE PREPARATION OF N-VINYLCARBOXAMIDES - Process for the preparation of N-vinylcarboxamides by pyrolysis of a compound of the formula | 2011-10-06 |
20110245540 | PROCESS FOR PRODUCING XYLYLENEDIAMINE - The invention provides a process for producing xylylenediamine, including supplying a solution of phthalonitrile dissolved in a solvent to a reactor filled with a catalyst and hydrogenating the phthalonitrile to produce xylylenediamine, characterized in that the process includes halting supply of the solution; (2) bringing a washing liquid into contact with the catalyst, the washing liquid having a phthalonitrile content of 3 mass % or less and a xylylenediamine content of 1 mass % or more; and after completion of the contact, resuming supply of the solution, and employing the catalyst continuously in hydrogenation. Through the production process of the invention, the catalyst can be employed continuously for a long period of time, and the catalyst-related cost can be considerably reduced. | 2011-10-06 |
20110245541 | Charge Transport Molecules And Method For Preparing Same - A compound of the formula | 2011-10-06 |
20110245542 | SYNTHESIS OF LIQUID FUELS AND CHEMICALS FROM OXYGENATED HYDROCARBONS - Processes and reactor systems are provided for the conversion of oxygenated hydrocarbons to hydrocarbons, ketones and alcohols useful as liquid fuels, such as gasoline, jet fuel or diesel fuel, and industrial chemicals. The process involves the conversion of mono-oxygenated hydrocarbons, such as alcohols, ketones, aldehydes, furans, carboxylic acids, diols, triols, and/or other polyols, to C | 2011-10-06 |
20110245543 | SYNTHESIS OF LIQUID FUELS AND CHEMICALS FROM OXYGENATED HYDROCARBONS - Processes and reactor systems are provided for the conversion of oxygenated hydrocarbons to hydrocarbons, ketones and alcohols useful as liquid fuels, such as gasoline, jet fuel or diesel fuel, and industrial chemicals. The process involves the conversion of mono-oxygenated hydrocarbons, such as alcohols, ketones, aldehydes, furans, carboxylic acids, diols, triols, and/or other polyols, to C | 2011-10-06 |
20110245544 | PROCESS FOR PREPARING HYDROXY-SUBSTITUTED AROMATIC ALDEHYDES - The present invention therefore relates to a process for preparing an aldehyde of the formula (I) | 2011-10-06 |
20110245545 | METHODS FOR PRODUCING PYROLYSIS PRODUCTS - The present invention provides pyrolysis products that have greater stability than pyrolysis products obtained from conventional pyrolysis production processes. The invention involves pyrolyzing a hydrocarbon feedstock in the presence of a basic metal oxide catalyst to produce a pyrolysis product. The pyrolysis product of the present invention can advantageously be particularly high in alcohol content. | 2011-10-06 |
20110245546 | Ethanol Production from Acetic Acid Utilizing a Cobalt Catalyst - A process for the selective production of ethanol by vapor phase reaction of acetic acid over a hydrogenating catalyst composition to form ethanol is disclosed and claimed. In an embodiment of this invention reaction of acetic acid and hydrogen over either cobalt and palladium supported on graphite or cobalt and platinum supported on silica selectively produces ethanol in a vapor phase at a temperature of about 250° C. | 2011-10-06 |
20110245547 | ADIABATIC PROCESS FOR MAKING MONONITROBENZENE - An adiabatic process for making mononitrobenzene by the nitration of benzene which minimizes the formation of nitrophenols and dinitrobenzene by-products. The process uses a mixed acid having less than 3 wt % nitric acid, 55 to 80 wt % sulfuric acid, and water. The initial temperature of the mixed acid is in the range of 60 to 96° C. The nitration reaction is complete in about 300 seconds and produces less than 1,200 ppm nitrophenols and less than about 80 ppm dinitrobenzene. The reaction can be carried out in a plug-flow or a stirred pot reactor, or a combination of such reactors. | 2011-10-06 |
20110245548 | CATALYST LIFE IMPROVEMENT IN THE VAPOR PHASE FLUORINATION OF CHLOROCARBONS - The present invention achieves a catalyst life improvement for the catalyzed vapor phase fluorination of a chlorocarbon in the presence of one catalyst and an oxygen feed. Specifically, in one non-limiting embodiment, the instant invention provides the conversion of 1,1,2,3-tetrachloropropene and/or 1,1,1,2,3-pentachloropropane to 2-chloro-3,3,3-trifluoropropene by introduction of a catalyst and oxygen co-feed to the fluorination reactor. | 2011-10-06 |
20110245549 | Integrated Process to Co-Produce Trans-1-Chloro-3,3,3-Trifluoropropene and Trans-1,3,3,3-Tetrafluoropropene - The disclosed integrated manufacturing process includes a combined liquid phase reaction and purification operation which directly produces trans-1-chloro-3,3,3-trifluoropropene and 3-chloro-1,1,1,3-tetrafluoropropane which is a precursor to the manufacture of trans-1,3,3,3-tetrafluoropropene. The mixture of co-products is easily separated by conventional distillation and 3-chloro-1,1,1,3-tetrafluoropropane is then dehydrochlorinated to produce trans-1,3,3,3-tetrafluoropropene by contacting in the liquid phase with a caustic solution or in the vapor phase using a dehydrochlorination catalyst. | 2011-10-06 |
20110245550 | PROCESS FOR PREPARING IODINATED AROMATIC COMPOUNDS - The present invention relates to a process for preparing iodinated aromatic compounds. Particularly, the present invention comprises the step of performing the iodination of a non-halogenated aromatic compound, a monoiodo aromatic compound, a diiodo aromatic compound, and iodine in the presence of a zeolite catalyst under oxygen atmosphere. | 2011-10-06 |
20110245551 | USE OF A GUARD BED REACTOR TO IMPROVE CONVERSION OF BIOFEEDSTOCKS TO FUEL - The present invention involves a process for processing an acidic biorenewable feedstock comprising olefins, in which the acidic biorenewable feedstock is diluted with a deoxygenated feed to produce a diluted biorenewable feedstock and then is sent through a guard bed comprising a hydroprocessing catalyst to cause the olefins to be saturated with hydrogen and thereby to produce a treated biorenewable feedstock. This treated biorenewable feedstock can then be treated under standard hydroprocessing condition to produce an upgraded feedstock for transportation fuels. | 2011-10-06 |
20110245552 | ALGAE PROCESSING - A method for culturing algae comprising, forming an emulsion comprising a gaseous stream and a media utilizing a high shear device, wherein the emulsion comprises gas bubbles, and wherein the high shear device comprises at least one toothed rotor and at least one stator; introducing the emulsion into a bioreactor; and introducing an algae into the bioreactor for growing the algae culture. Additionally, a method for producing liquids from an algae culture, the method comprising forming an emulsion comprising a buffer and algal components, wherein the emulsion comprises algal component globules; separating algal hydrocarbons; and processing algal hydrocarbons to form liquid hydrocarbons. Additionally, a system for producing liquids from an algae culture comprising at least one high shear device. | 2011-10-06 |
20110245553 | PRODUCTION OF DIESEL FUEL FROM BIORENEWABLE FEEDSTOCKS WITH SELECTIVE SEPARATION OF CONVERTED OXYGEN - A process has been developed for producing diesel boiling range fuel from renewable feedstocks such as fats and oils from plants and animals where the process provides for sulfur-component management. The process involves catalytically treating a renewable feedstock by hydrogenating and deoxygenating to provide a hydrocarbon fraction useful as a diesel boiling range fuel. A selective separation such as a hot high pressure hydrogen stripper may be used to remove at least the carbon oxides from the first zone effluent and provide a liquid recycle stream at pressure and temperature. A vapor stream is separated from the net process effluent and at least carbon dioxide is removed using at least one selective or flexible amine absorber. The resulting hydrogen-rich stream is recycled to the reaction zone. | 2011-10-06 |
20110245554 | Production of Hydrogen, Liquid Fuels, and Chemicals from Catalytic Processing of Bio-Oils - Disclosed herein is a method of generating hydrogen from a bio-oil, comprising hydrogenating a water-soluble fraction of the bio-oil with hydrogen in the presence of a hydrogenation catalyst, and reforming the water-soluble fraction by aqueous-phase reforming in the presence of a reforming catalyst, wherein hydrogen is generated by the reforming, and the amount of hydrogen generated is greater than that consumed by the hydrogenating. The method can further comprise hydrocracking or hydrotreating a lignin fraction of the bio-oil with hydrogen in the presence of a hydrocracking catalyst wherein the lignin fraction of bio-oil is obtained as a water-insoluble fraction from aqueous extraction of bio-oil. The hydrogen used in the hydrogenating and in the hydrocracking or hydrotreating can be generated by reforming the water-soluble fraction of bio-oil. | 2011-10-06 |